When the same set of AP signature genes was analysed in other cell lines, including the CRC HCT116 cells, breast cancer MCF7 cells and lung cancer A549 cells, CXD101 treatment caused a similar increase in gene expression (Fig. S2B–G). This evidence concerns the gene DHCR7-DT and breast cancer.